DE105221T1 - Verfahren zur bestimmung von interferon und satz zur pruefung von interferon. - Google Patents

Verfahren zur bestimmung von interferon und satz zur pruefung von interferon.

Info

Publication number
DE105221T1
DE105221T1 DE198383108837T DE83108837T DE105221T1 DE 105221 T1 DE105221 T1 DE 105221T1 DE 198383108837 T DE198383108837 T DE 198383108837T DE 83108837 T DE83108837 T DE 83108837T DE 105221 T1 DE105221 T1 DE 105221T1
Authority
DE
Germany
Prior art keywords
virus
lysed
enzyme
elisa
interferon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE198383108837T
Other languages
English (en)
Inventor
Michel Revel
David Rehovot Wallach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Publication of DE105221T1 publication Critical patent/DE105221T1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6866Interferon
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/84Brevibacterium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/828Protein A

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Claims (8)

EP 83 10 8837.2 Yeda Research and Development Co., Ltd. 2 0. Sep. our ref.: S 603 EP Patentansprüche (deutsche Übersetzung nach Artikel 67 EPÜ)
1. Verfahren zur Bestimmung von Interferon (IFN), dadurch gekennzeichnet,
daß geeignete Zellen in Gewebekultur gezüchtet werden, einer_solchen Zellkultur eine zu messende IFN-Probe zugegeben wird, die Zellen mit einem geeigneten Virus infiziert werden, diese für eine bestimmte Zeitspanne inkubiert werden, das Virus durch Verwendung eines geeigneten Detergenz lysiert wird und, daß der Virusproteingehalt der lysierten Proben bestimmt wird.
2. Verfahren nach Anspruch 1, bei dem das verwendete Virus das Vesicular-Stomatitis-Virus (VSV) ist.
3. Verfahren nach Anspruch 1 oder 2, bei dem die Virusinfizierten Zellkulturen lysiert werden und in PVC-Gefäße gefüllt werden.
.
4. Verfahren nach Anspruch 3, bei dem die Gefäße PVC-Mikroplatten sind.
5. Verfahren nach Anspruch 3 oder 4, bei dem das PVC- ^O gebundene Protein mit anti-VSV-Antikörpern inkubiert wird und das absorbierte IgG gemessen wird.
6. Verfahren nach einem der Ansprüche 1 bis 5, bei dem die lysierten Viren durch einen Radioimmunoassay oder einen EL'ISA-Test gemessen werden.
7. Ausrüstung zur Ausführung eines IFN-Tests, die insgesamt enthält:
a. Lyophilisierte Virusprobe
b. Lysis-Puffer
c. Tween-PBS-Puffer
d. Eines der folgenden:
(I) gereinigtes anti-Virus-Immunoglobulin,das an ein für die Verwendung bei ELISA geeignetes Enzym gekoppelt ist,
1 25
(II) anti-Virus-Serum und j-markiertes Protein A
(III) anti-Virus-Serum und Enzym-gekoppeltes anti-IgG-Serum für (I) oder (III), ein Substrat für das Enzym, das beim ELISA verwendet wird und eine Stop-Lösung, die die Spaltung dieses Substrats durch das Enzym beendet
e. Mikroplatten für ELISA (I) oder (III) oder für RIA (II)
8. Ausrüstung nach Anspruch 7, bei der das Virus VSV ist.
DE198383108837T 1982-09-07 1983-09-07 Verfahren zur bestimmung von interferon und satz zur pruefung von interferon. Pending DE105221T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL66733A IL66733A (en) 1982-09-07 1982-09-07 Assay for ifn and kit therefor

Publications (1)

Publication Number Publication Date
DE105221T1 true DE105221T1 (de) 1985-02-14

Family

ID=11053747

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8383108837T Expired DE3370543D1 (en) 1982-09-07 1983-09-07 Process for the determination of interferon and kit for the assay of interferon
DE198383108837T Pending DE105221T1 (de) 1982-09-07 1983-09-07 Verfahren zur bestimmung von interferon und satz zur pruefung von interferon.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE8383108837T Expired DE3370543D1 (en) 1982-09-07 1983-09-07 Process for the determination of interferon and kit for the assay of interferon

Country Status (8)

Country Link
US (1) US4622292A (de)
EP (1) EP0105221B1 (de)
JP (1) JPS5965765A (de)
AU (1) AU572790B2 (de)
CA (1) CA1223811A (de)
DE (2) DE3370543D1 (de)
IL (1) IL66733A (de)
ZA (1) ZA836488B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675282A (en) * 1984-07-06 1987-06-23 Damon Biotech, Inc. Assay for interferon epsilon
CA1317860C (en) * 1987-04-01 1993-05-18 Daniel Louis Kacian Techniques for preparing specimens for bacterial assays
US7007179B2 (en) * 2001-02-08 2006-02-28 Honeywell International Inc. Electric load management center
US7139404B2 (en) 2001-08-10 2006-11-21 Hear-Wear Technologies, Llc BTE/CIC auditory device and modular connector system therefor
US7110562B1 (en) 2001-08-10 2006-09-19 Hear-Wear Technologies, Llc BTE/CIC auditory device and modular connector system therefor
JP4889505B2 (ja) 2004-02-02 2012-03-07 アンブレツクス・インコーポレイテツド 被修飾されたヒト成長ホルモンポリペプチドおよびこれらの使用
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910824A (en) * 1973-10-18 1975-10-07 Searle & Co Interferon assay
DE2941575A1 (de) * 1978-10-19 1980-04-30 Harvard College Methode zur identifizierung einer virusinfektion und kit hierfuer
WO1982001773A1 (en) * 1980-11-07 1982-05-27 Secher David S Assay for interferon

Also Published As

Publication number Publication date
DE3370543D1 (en) 1987-04-30
ZA836488B (en) 1984-04-25
AU1869383A (en) 1984-03-15
JPH0331389B2 (de) 1991-05-02
EP0105221A1 (de) 1984-04-11
AU572790B2 (en) 1988-05-19
IL66733A0 (en) 1982-12-31
CA1223811A (en) 1987-07-07
US4622292A (en) 1986-11-11
JPS5965765A (ja) 1984-04-14
EP0105221B1 (de) 1987-03-25
IL66733A (en) 1986-03-31

Similar Documents

Publication Publication Date Title
Kirchner et al. A whole-blood technique for testing production of human interferon by leukocytes
Landegren Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens
Funakoshi et al. Human carbonic anhydrases: II. Some physicochemical properties of native isozymes and of similar isozymes generated in vitro
ATE81722T1 (de) Verfahren zur bestimmung von mimotopen.
DE105221T1 (de) Verfahren zur bestimmung von interferon und satz zur pruefung von interferon.
DE2930706A1 (de) Verfahren zum nachweis von erregerspezifischen antikoerpern
GB1436934A (en) Method of testing blood
De Groote et al. Novel method for the measurement of cytokine production by a one-stage procedure
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
EP0140379A3 (en) Method and apparatus for measuring the degree of reaction between antigens and leukocyte cellular antibodies
DE3855890D1 (de) Verfahren zur herstellung von imunodiagnose-mitteln
ATE120549T1 (de) Verfahren zur bestimmung von hiv-antikörpern.
CA2140794A1 (en) Assay for the determination of protein in a biological sample
DE69131579D1 (de) Synthetisches antigen einer alternden zelle
GB1529891A (en) Detection of hepatitis b surface antigen by latex agglutination
EP0230934A3 (de) Monoklonaler Antikörper, Verfahren zur Messung eines glucosylierten Proteins unter Verwendung von diesem monoklonalen Antikörper, und Kit dafür
Zaidi et al. Molecular composition of human luteinizing hormone: biological and immunological profiles of highly purified preparations after electrofocusing
Rush et al. Measurement of human dopamine-beta-hydroxylase in serum by homologous radioimmunoassay.
ATE130683T1 (de) Immunologisches präzipitationsverfahren zur bestimmung eines bindefähigen analyten sowie reagenz zur durchführung dieses verfahrens.
EP0282021A3 (de) Spezifische Antikörper gegen Herzmuskelmyosin-Leichtketten, ihre Herstellung und Verwendung in einem Reagenz zur Bestimmung von Herzmuskelmyosin-Leichtketten
David et al. Inability to detect Ia antigens in mouse sera
ATE94994T1 (de) Verfahren und reagenz zur bestimmung von eisen.
Nossel Secreted platelet proteins
Katsumata et al. Changes in plasma thyroglobulin levels in experimentally aged blood
Eberhart et al. The electrophoretic analysis of the third component of complement (C3) in dried bloodstains